DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Development of an Omnidirectional Transport Robot Strong Against Steps
The Tokyo Metropolitan Industrial Technology Research Center has developed an omnidirectional transport robot with step-climbing performance enhanced by up to 7.5 times compared to conventional models. This technology allows the robot to change the "toe angle" of its wheels from 0 to 25 degrees during operation without altering wheel size, significantly improving its ability to overcome steps, increasing propulsion by 1.5 times, and maintaining high positioning accuracy. Expected to automate transport in various confined spaces such as construction sites, factories, warehouses, and medical facilities, a live demonstration is scheduled at the 10th Robot Exhibition (RoboDEX).
Researchers’ Sweat-Based Sensor May Help Improve Sleep Quality
Researchers at the University of Texas at Dallas, in partnership with EnLiSense, have developed a pioneering wearable perspiration-based sensor that measures two key hormones regulating the body's sleep-wake cycle. This electrochemical sensor continuously monitors cortisol, which promotes wakefulness, and melatonin, which signals the body to sleep. Compared to existing methods involving salivary samples, this technology allows continuous measurement of hormones through passive sweat, reducing patient burden in sleep studies and providing more objective data. This is expected to contribute to improving sleep quality.
Reading Invisible Biological Information with Light: Near-Infrared Fluorescence Probe Visualizes Deep Tissues, Taking Drug Evaluation to the Next Level of Resolution
The Sciforiem® FI Series developed by artience is a near-infrared fluorescent probe designed to advance the observation of cells and biomolecules in regenerative medicine and drug discovery research. By utilizing near-infrared light with high tissue penetration, it enables imaging deep within living tissue and of microscopic structures, allowing prolonged observation of cell and protein dynamics.
The company's founding business was ink development, cultivating material design technologies that impart various functions to polymers and pigments. As an application of this core technology to the life sciences field, it is advancing the development of fluorescent dyes and additives for in vitro diagnostic reagents.
This series features high fluorescence intensity and photostability, resisting degradation even in high-power laser environments like super-resolution microscopy, enabling uniform cell labeling. It facilitates more precise evaluations in drug discovery screening, such as high-content analysis. It also addresses traditional challenges like tendency to aggregate in vivo and poor penetration through unique molecular design.
Furthermore, it can label microparticles like exosomes and liposomes without causing aggregation, making it promising for applications in intercellular communication research and drug delivery evaluation. Broad applications are also envisioned, including gene amplification labeling, immunohistochemistry, flow cytometry, and in vitro diagnostics utilizing fluorescence.
The company is focusing on the life sciences field as one of its next-generation businesses. Mr. Hatano, the bio-related manager, states, “As high-resolution imaging and trace detection advance, the design technology for the dye itself becomes increasingly critical. This is where our company's cultivated expertise in organic synthesis and dye design comes into play.” We are entering an era where the precision of bio-research is determined not only by equipment but also by materials. Dye design born from materials technology is poised to enhance its presence as a foundational technology for next-generation bio-observation.
PBS Biotech Unveils a Breakthrough Product for Cell Therapy Process Development at ISSCR, Boston
PBS Biotech, a leader in single-use bioreactor technology, has launched MiniPRO™, a multi-parallel Vertical-Wheel® bioreactor platform. MiniPRO™ allows researchers to simultaneously run up to 24 independent, small-scale cultures in an automated closed system with real-time control and monitoring of temperature, agitation, oxygenation, pH, and perfusion media exchange. This technology is designed to streamline cell therapy process development, enabling efficient optimization and scale-up of manufacturing processes, thereby reducing time and costs. Built on PBS Biotech's patented Vertical-Wheel® technology, MiniPRO™ ensures that laboratory-developed processes can be confidently transferred to clinical production, bridging the gap towards standardized, scalable cell therapy manufacturing.
Bio-sensor system developed that measures sweat lactate simply by attaching to skin—obtains medical device manufacturing and sales approval, offering new hope for exercise therapy in heart disease patients—
Yoshiki Katsumata, Assistant Professor at the Keio University School of Medicine Sports Medicine Center (Professor: Kazuki Sato), and Yasunori Shiraishi, Assistant Professor at the Department of Internal Medicine (Cardiology) (Professor: Maki Ieda), in collaboration with Grace Imaging Inc. (CEO: Daisuke Nakajima), developed a sweat lactate sensor capable of continuously monitoring lactate levels in sweat. In 2022, they conducted a physician-initiated clinical trial (Reference 1: Clinical Trial Protocol Number LacS-001; jRCT2032220057). This trial evaluated the performance of the sweat lactate sensor in estimating the anaerobic threshold (AT: a key indicator for exercise prescription in cardiac rehabilitation) in patients with heart disease and achieved its primary endpoint. Based on these trial results, we submitted an application for medical device approval for a system using the sweat lactate sensor to estimate AT. On December 3, 2025, approval for manufacturing and marketing of the medical device was granted.
Joint research with Tohoku University published in international journal on smart and nanomaterials
Nikkiso Co., Ltd. announced that the results of its joint research with Tohoku University on autonomously detecting internal damage in aerospace-grade Carbon Fiber Reinforced Plastic (CFRP) using a self-powered material have been published in an international journal specializing in smart and nanomaterials. The research successfully developed a unique structure by laminating lead-free piezoelectric material "Potassium Sodium Niobate (KNN)" into CFRP, enabling quantitative detection of damage (crack propagation) without external power, a groundbreaking achievement contributing to the development of safer mobility.
Developed an AI model to predict the continuity of blood pressure measurements using approximately 300,000 sets of home blood pressure data
A research group (hereinafter referred to as the research group) from the joint research program between the Graduate School of Medicine, Kyoto University (Professor Yasushi Okuno, hereinafter Kyoto University) and Omron Healthcare Co., Ltd. (Headquarters: Mukō City, Kyoto Prefecture; President: Ayumu Okada, hereinafter Omron Healthcare) has developed an AI model that predicts the continuity of blood pressure measurements based on two weeks of measurement data and user attributes. This was achieved by analyzing large-scale home blood pressure measurement data from approximately 300,000 users of Omron Healthcare's health management app.
The research paper, “Predicting measurement continuity in home blood pressure monitoring using machine learning,” was published in Hypertension Research on November 7, 2025.
UCC Tyndall Institute Develops BioSensors To Detect Harmful "Forever Chemicals"
A new EU-funded project led by UCC’s Tyndall National Institute is developing cutting-edge biosensors that use bacteria to detect harmful “forever chemicals” in the marine and terrestrial environment.
“Forever chemicals” include a group of persistent pollutants known as PFAS (per- and polyfluoroalkyl substances) found in everyday items.
They are increasingly found in our environment and pose serious risks to human health and ecosystems.
Their presence threatens the integrity of natural resources and has been linked to cancer, high cholesterol, reproductive issues, hormonal disruption, and weakened immunity.
Funded by the European Commission, the BIOSENSEI project brings together ten partners from across Europe to create real-time, multiplexed, end-to-end biosensors that will detect “forever chemicals” in the environment.
BIOSENSEI is developing scalable biosensors for water and soil applications.
Designer enzyme enables yeast to produce custom fatty acids, reducing need for palm oil
Whether they are laundry detergents, mascara, or Christmas chocolate, many everyday products contain fatty acids from palm oil or coconut oil. However, the extraction of these raw materials is associated with massive environmental issues: Rainforests are cleared, habitats for endangered species are destroyed, and traditional farmers lose their livelihoods.
Cleveland researchers discover enzyme that could lead to new obesity treatment
Researchers at University Hospitals and Case Western Reserve University have discovered an enzyme that appears to play a key role in fat production, a finding that could lead to a three-in-one drug to treat obesity, fatty liver disease, and cardiovascular disease.
The research team identified an enzyme called SCoR2 that removes nitric oxide from proteins that control fat buildup in the body. When they blocked this enzyme in mice, the animals did not gain weight and showed lower cholesterol levels and reduced liver injury, researchers said.
How Radar Technology is Revolutionizing Elderly Sleep Monitoring
Radar technology is revolutionizing sleep monitoring for the elderly. Replacing cameras and wearable devices, radar protects privacy while non-invasively detecting sleep movements, breathing patterns, and even issues like sleep apnea and falls with high accuracy. These compact sensors integrate with smart home devices, enabling seniors to live independently longer at home or in care facilities while providing caregivers with vital health information.
Study Raises Serious Questions About The Benefits of Intermittent Fasting
The notion behind intermittent fasting is simple: eat less for a time, improve your metabolism. The reality is more complex, and a new study finds that some forms of intermittent fasting do not alter markers of metabolic or cardiovascular health.
Researchers, led by a team from the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), put 31 women who were overweight or obese on two different intermittent fasting schedules for two weeks each.
The schedules were 8 am to 4 pm or 1 pm to 9 pm, a particular kind of intermittent fasting known as time-restricted eating (TRE).
While the timing of the schedules differed, the diet parameters were the same: participants could eat like they normally did, and therefore take in the same amount of total calories (making this what's known as an isocaloric study).
AI Meets Enzymes: eXoZymes Enables High-Yield Production of Compounds Previously Impossible to Make
Chemical compounds with high therapeutic value often come with an impossible catch: they exist in tiny amounts in rare plants, fungi, or other natural sources. Extracting them can take tons of raw material, leaving environmental scars, or require toxic petrochemical processes that produce hazardous waste. For decades, scientists tried to overcome these limits by using synthetic biology: engineering living cells to produce molecules, but scaling these methods from lab to factory remained a near-impossible challenge. Yields were low, cells resisted foreign tasks, and production often failed to reach commercial levels.
A new class of technology is emerging to tackle this challenge. It combines the elegance of nature's chemistry with the analytical power of artificial intelligence. Instead of relying on living cells, these systems use enzymes as the workhorses, enhancing them so they can operate independently in a controlled bioreactor. The result is a production platform that promises efficiency and scalability previously thought unattainable.